Clinical efficacy of 0.75% ropivacaine vs. 2% lignocaine hydrochloride with adrenaline (1:80,000) in patients undergoing removal of bilateral maxillary third molars: a randomized controlled trial
Kakade Aniket Narayan, Joshi Sanjay S., Naik Charudatta Shridhar, Mhatre Bhupendra Vilas, Ansari Arsalan,
소속 상세정보
( Kakade Aniket Narayan ) - Terna Dental College Department of Oral and Maxillofacial Surgery
( Joshi Sanjay S. ) - Terna Dental College Department of Oral and Maxillofacial Surgery
( Naik Charudatta Shridhar ) - Terna Dental College Department of Oral and Maxillofacial Surgery
( Mhatre Bhupendra Vilas ) - Terna Dental College Department of Oral and Maxillofacial Surgery
( Ansari Arsalan ) - Terna Dental College Department of Oral and Maxillofacial Surgery
Abstract
Background: Lignocaine with adrenaline is routinely used as a local anesthetic for dental procedures. Adrenaline was added to increase the duration of anesthesia. However, epinephrine containing a local anesthetic solution is not recommended in conditions such as advanced cardiovascular diseases and hyperthyroidism. Recently, ropivacaine has gained popularity as a long-acting anesthetic with superior outcomes. The goal of this study was to assess and compare the effectiveness of 0.75% ropivacaine alone and 2% lignocaine with adrenaline (1:80,000) in the removal of bilateral maxillary wisdom teeth using the posterior superior alveolar nerve block technique.
Methods: This was a single-blind, randomized, split-mouth, prospective study assessing 15 systemically sound outpatients who needed bilateral removal of maxillary third molars. We randomly allocated the sides and sequences of ropivacaine and lignocaine with adrenaline administration. We evaluated the efficacy of both anesthetics with regard to the onset of anesthesia, intensity of pain, variation in heart rate, and blood pressure.
Results: The onset of anesthesia was faster with lignocaine (138 s) than with ropivacaine (168 s), with insignificant differences (p = 0.001). There was no need for additional local anesthetics in the ropivacaine group, while in the lignocaine with adrenaline group, 2 (13.3%) patients required additional anesthesia. Adequate intraoperative anesthesia was provided by ropivacaine and lignocaine solutions. No significant difference was observed in the perioperative variation in blood pressure and heart rate.
Conclusion: Ropivacaine (0.75%) is a safe and an adrenaline-free local anesthetic option for posterior superior alveolar nerve block, which provides adequate intraoperative anesthesia and a stable hemodynamic profile for the removal of the maxillary third molar.
키워드
Analgesia; Anesthesia; Lignocaine; Ropivacaine
원문 및 링크아웃 정보
등재저널 정보